Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Cochlear ( (AU:COH) ) is now available.
Cochlear Limited has announced an extension of its existing on-market buy-back program for its fully paid ordinary shares. This move indicates the company’s commitment to optimizing its capital structure and potentially enhancing shareholder value, reflecting a strategic approach to managing its financial resources.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$311.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in the development and manufacturing of implantable hearing solutions. The company is known for its innovative cochlear implants and other hearing-related products, catering primarily to individuals with severe to profound hearing loss.
Average Trading Volume: 173,116
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$20.4B
For an in-depth examination of COH stock, go to TipRanks’ Overview page.